Answers are grounded in this paper and cite their sources.
This study describes a successful, targeted intervention in central venous access device routine care to decrease central line-associated bloodstream infection. Taurolidine-citrate locks significantly reduced the rate of central line-associated bloodstream infection, particularly Gram-negative organisms without adverse events.
No takes yet. Share an insight, caveat, or question.
Clark et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: